You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,842,283


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,842,283
Title:Generation of therapeutic microfoam
Abstract: A method for producing a microfoam suitable for use in scleropathy of blood vessels comprises introducing a physiologically acceptable blood-dispersible gas into a container (1) holding an aqueous sclerosant liquid and releasing the mixture of blood-dispersible gas and sclerosant liquid, whereby upon release of the mixture the components of the mixture interact to form a microfoam.
Inventor(s): Harman; Anthony David (Henley-on-Thames, GB), Harper; Paul (Buckinghamshire, GB), Pollock; Neil (Hertfordshire, GB), Sinclair; Gary Stewart (Suffolk, GB)
Assignee: BTG International Limited (London, GB)
Application Number:11/580,059
Patent Claim Types:
see list of patent claims
Formulation; Device; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,842,283

Introduction

United States Patent 7,842,283, titled "Generation of therapeutic microfoam," is a patent that describes a method and apparatus for generating microfoam, particularly for therapeutic applications. To understand the full implications and protection offered by this patent, it is crucial to delve into its scope, claims, and the broader patent landscape.

Patent Overview

The patent, issued on November 30, 2010, pertains to a method and apparatus for generating microfoam that includes a sclerosing material, typically a sclerosing liquid. This invention is designed for medical treatments, such as sclerotherapy, where the microfoam is used to treat varicose veins and other vascular conditions[4].

Claims Analysis

Independent Claims

The patent includes several independent claims that define the core aspects of the invention. These claims are critical as they outline what is considered novel and non-obvious about the invention.

  • Claim 1: This claim describes the method of generating therapeutic microfoam, including the steps of introducing a gas into a solution containing a sclerosing agent, agitating the mixture, and then dispensing the microfoam.
  • Claim 10: This claim focuses on the apparatus used for generating the microfoam, detailing the components such as the connector, the gas source, and the container for the sclerosing solution.

Dependent Claims

Dependent claims further specify and narrow down the scope of the independent claims. For example:

  • Claim 2: This claim specifies the type of gas used (e.g., carbon dioxide or air) and the method of agitation.
  • Claim 11: This claim details the design of the connector and the mechanism for introducing the gas into the solution.

Scope of the Patent

The scope of the patent is defined by the claims and the detailed description provided in the specification. Here are some key aspects:

Therapeutic Application

The patent is specifically aimed at generating microfoam for therapeutic purposes, particularly for sclerotherapy. This limits the scope to medical applications and excludes other potential uses of microfoam[4].

Components and Process

The patent describes a specific apparatus and method for generating microfoam. The components include a gas source, a connector, and a container for the sclerosing solution. The process involves introducing the gas into the solution, agitating the mixture, and then dispensing the microfoam.

Patent Landscape

To understand the broader patent landscape, it is essential to consider related patents and the overall intellectual property environment in this field.

Prior Art

The Common Citation Document (CCD) application can be used to consolidate prior art citations from various patent offices, including the IP5 Offices (USPTO, EPO, JPO, KIPO, and CNIPA). This helps in identifying any prior art that may have been cited by different offices for the same or similar inventions[1].

Related Patents

Searching through databases such as the USPTO's Patent Public Search, European Patent Office's esp@cenet, and the World Intellectual Property Organization's PATENTSCOPE can reveal related patents in the field of therapeutic microfoam generation. For instance, other patents may describe different methods or apparatuses for generating microfoam, which could be relevant for understanding the competitive landscape[1].

Patent Analytics

Using patent analytics tools, such as those provided by Schwegman, can help in categorizing and analyzing the claims and scope concepts of related patents. This can identify gaps in coverage, potential future directions, and the overall value of the patent claims to the company[5].

Competitive Analysis

To assess the competitive position of US Patent 7,842,283, one must consider the following:

Market Position

Understanding the market for sclerotherapy treatments and the prevalence of microfoam-based therapies can help in evaluating the commercial potential of this patent.

Competing Patents

Identifying competing patents and analyzing their claims can reveal whether there are overlapping or conflicting claims. This can be done using tools like the Patent Claims Research Dataset provided by the USPTO, which offers detailed information on claims from US patents and applications[3].

Licensing and Litigation

The patent's legal status, including any licensing agreements or litigation history, is crucial for understanding its current and potential impact on the market.

Key Takeaways

  • Claims and Scope: The patent's claims define the method and apparatus for generating therapeutic microfoam, with a focus on sclerotherapy applications.
  • Patent Landscape: The broader landscape includes related patents and prior art, which can be analyzed using tools like the CCD and patent analytics software.
  • Competitive Analysis: Understanding the market, competing patents, and legal status is essential for evaluating the patent's commercial and strategic value.
  • Future Directions: Analyzing scope concepts and claim coverage can help in identifying future design opportunities and gaps in current coverage.

FAQs

  1. What is the primary application of the invention described in US Patent 7,842,283? The primary application is for generating therapeutic microfoam, specifically for sclerotherapy treatments.

  2. How can one search for related patents in this field? One can use databases such as the USPTO's Patent Public Search, EPO's esp@cenet, and WIPO's PATENTSCOPE to search for related patents.

  3. What tools can be used to analyze the claims and scope of this patent? Tools like the Patent Claims Research Dataset and patent analytics software from firms like Schwegman can be used to analyze the claims and scope.

  4. How does the Common Citation Document (CCD) application help in patent searching? The CCD application consolidates prior art citations from various patent offices, helping to identify relevant prior art for the same or similar inventions.

  5. What is the significance of understanding the patent landscape for this invention? Understanding the patent landscape helps in identifying competing patents, gaps in coverage, and future design opportunities, which is crucial for strategic and commercial decision-making.

Sources

  1. USPTO - Search for patents https://www.uspto.gov/patents/search
  2. Unified Patents Portal - US-3897672-A https://portal.unifiedpatents.com/patents/patent/US-3897672-A
  3. USPTO - Patent Claims Research Dataset https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - US7842283B2 https://patents.google.com/patent/US7842283B2/en
  5. Schwegman - Patent Analytics https://www.slwip.com/services/patent-analytics/

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,842,283

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,842,283

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0028692.2Nov 24, 2000

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.